381 related articles for article (PubMed ID: 23995370)
1. Strategies for safe donor expansion: donor management, donations after cardiac death, ex-vivo lung perfusion.
Cypel M; Keshavjee S
Curr Opin Organ Transplant; 2013 Oct; 18(5):513-7. PubMed ID: 23995370
[TBL] [Abstract][Full Text] [Related]
2. Expanding the lung donor pool: advancements and emerging pathways.
Reeb J; Keshavjee S; Cypel M
Curr Opin Organ Transplant; 2015 Oct; 20(5):498-505. PubMed ID: 26262464
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal lung perfusion (ex-vivo lung perfusion).
Cypel M; Keshavjee S
Curr Opin Organ Transplant; 2016 Jun; 21(3):329-35. PubMed ID: 27145198
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal lung perfusion.
Cypel M; Keshavjee S
Curr Opin Organ Transplant; 2011 Oct; 16(5):469-75. PubMed ID: 21857514
[TBL] [Abstract][Full Text] [Related]
5. Experience with the first 50 ex vivo lung perfusions in clinical transplantation.
Cypel M; Yeung JC; Machuca T; Chen M; Singer LG; Yasufuku K; de Perrot M; Pierre A; Waddell TK; Keshavjee S
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1200-6. PubMed ID: 22944089
[TBL] [Abstract][Full Text] [Related]
6. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
[TBL] [Abstract][Full Text] [Related]
7. Extending the donor pool: rehabilitation of poor organs.
Cypel M; Keshavjee S
Thorac Surg Clin; 2015; 25(1):27-33. PubMed ID: 25430427
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of initially rejected donor lungs after ex vivo lung perfusion.
Wallinder A; Ricksten SE; Hansson C; Riise GC; Silverborn M; Liden H; Olausson M; Dellgren G
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1222-8. PubMed ID: 22995721
[TBL] [Abstract][Full Text] [Related]
9. The clinical potential of ex vivo lung perfusion.
Cypel M; Keshavjee S
Expert Rev Respir Med; 2012 Feb; 6(1):27-35. PubMed ID: 22283576
[TBL] [Abstract][Full Text] [Related]
10. Transplantation after ex vivo lung perfusion: A midterm follow-up.
Wallinder A; Riise GC; Ricksten SE; Silverborn M; Dellgren G
J Heart Lung Transplant; 2016 Nov; 35(11):1303-1310. PubMed ID: 27381674
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to expanding the lung donor pool: donation after cardiac death and ex vivo conditioning.
Cypel M; Yeung JC; Keshavjee S
Clin Chest Med; 2011 Jun; 32(2):233-44. PubMed ID: 21511086
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of Lung Transplantation From Donation After Circulatory Death Donors Following Portable Ex Vivo Lung Perfusion: A Pilot Study.
Luc JGY; Jackson K; Weinkauf JG; Freed DH; Nagendran J
Transplant Proc; 2017 Oct; 49(8):1885-1892. PubMed ID: 28923643
[TBL] [Abstract][Full Text] [Related]
13. An experimental study of the recovery of injured porcine lungs with prolonged normothermic cellular ex vivo lung perfusion following donation after circulatory death.
Spratt JR; Mattison LM; Iaizzo PA; Brown RZ; Helms H; Iles TL; Howard B; Panoskaltsis-Mortari A; Loor G
Transpl Int; 2017 Sep; 30(9):932-944. PubMed ID: 28493634
[TBL] [Abstract][Full Text] [Related]
14. Lungs from donation after circulatory death donors: an alternative source to brain-dead donors? Midterm results at a single institution.
Zych B; Popov AF; Amrani M; Bahrami T; Redmond KC; Krueger H; Carby M; Simon AR
Eur J Cardiothorac Surg; 2012 Sep; 42(3):542-9. PubMed ID: 22371518
[TBL] [Abstract][Full Text] [Related]
15. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Zhao Y; Grasemann H; Tavasoli F; Yeung JC; Bonato R; Chen M; Zamel R; Chun YM; Guan Z; de Perrot M; Waddell TK; Liu M; Keshavjee S
J Heart Lung Transplant; 2015 Jun; 34(6):849-57. PubMed ID: 25907141
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.
Wagner CE; Pope NH; Charles EJ; Huerter ME; Sharma AK; Salmon MD; Carter BT; Stoler MH; Lau CL; Laubach VE; Kron IL
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):538-45. PubMed ID: 26323621
[TBL] [Abstract][Full Text] [Related]
17. Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors.
Dong B; Stewart PW; Egan TM
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):429-36.e1. PubMed ID: 23260460
[TBL] [Abstract][Full Text] [Related]
18. Donation After Cardiac Death, a Possibility to Expand the Donor Pool: Review and the Hungarian Experience.
Ghimessy ÁK; Farkas A; Gieszer B; Radeczky P; Csende K; Mészáros L; Török K; Fazekas L; Agócs L; Kocsis Á; Bartók T; Dancs T; Tóth KK; Schönauer N; Madurka I; Elek J; Döme B; Rényi-Vámos F; Lang G; Taghavi S; Hötzenecker K; Klepetko W; Bogyó L
Transplant Proc; 2019 May; 51(4):1276-1280. PubMed ID: 31101213
[TBL] [Abstract][Full Text] [Related]
19. Progress of Clinical Application for Ex Vivo Lung Perfusion (EVLP) in Lung Transplantation.
Gu C; Pan X; Shi J
Methods Mol Biol; 2020; 2204():217-224. PubMed ID: 32710328
[TBL] [Abstract][Full Text] [Related]
20. Donor selection and management.
Snell GI; Paraskeva M; Westall GP
Semin Respir Crit Care Med; 2013 Jun; 34(3):361-70. PubMed ID: 23821510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
